Related Experiment Video
Updated: May 7, 2026
09:53
Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery
Published on: July 5, 2021
3.3K
[Patient with atypical neurocytoma - case report]
Summary
Neurocytoma, a rare central nervous system tumor, requires careful consideration for adjuvant radiotherapy timing. While it improves local control, potential long-term side effects must be weighed against survival benefits.
Area of Science:
- Neuro-oncology
- Central Nervous System Tumors
Background:
- Neurocytoma is a rare, slow-growing central nervous system tumor.
- Surgical resection offers a generally good prognosis, with or without adjuvant radiotherapy.
Observation:
- A case of a 25-year-old woman with a third ventricle neurocytoma presenting with syncope.
- Initial treatment involved gross total resection without adjuvant radiotherapy.
- Disease progression occurred 36 months post-surgery, leading to radiotherapy initiation.
Findings:
- Adjuvant radiotherapy is crucial for improving local control in neurocytoma management.
- The timing of radiotherapy is a significant challenge due to potential late side effects.
Implications:
- Balancing the benefits of radiotherapy for local control against risks of late side effects is critical.
- Personalized treatment strategies are essential for long-term neurocytoma patient survival.
